Greylock XI’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Greylock XI’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$707K	Hold	58,400	–	–	9.17%	2
2015 Q2	$1.02M	Hold	58,400	–	–	10.48%	2
2015 Q1	$847K	Hold	58,400	–	–	7.99%	2
2014 Q4	$491K	Hold	58,400	–	–	100%	1
2014 Q3	$648K	Hold	58,400	–	–	100%	1
2014 Q2	$1.07M	Hold	58,400	–	–	100%	1
2014 Q1	$876K	Hold	58,400	–	–	0.56%	2
2013 Q4	$1.07M	Hold	58,400	–	–	0.37%	2
2013 Q3	$1.2M	Hold	58,400	–	–	0.32%	3
2013 Q2	$1.46M	Buy	+58,400	New	+$2.5M	0.17%	3

Other funds holding AVEO

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

DVC

Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Greylock XI's AVEO Position: Q3 2015 in Review

Greylock XI held its AVEO Pharmaceuticals, Inc. (AVEO) position steady in Q3 2015 at 58,400 shares worth $707K. The position accounts for 9.17% of the portfolio, ranked #2.

Greylock XI first reported a position in AVEO in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.46M in Q2 2013. 48 funds tracked by Wall St. Rank hold AVEO as of Q3 2015.

Greylock XI held 58,400 shares of AVEO Pharmaceuticals, Inc. worth $707K as of Q3 2015.
Greylock XI left its AVEO Pharmaceuticals, Inc. share count unchanged in Q3 2015.
AVEO Pharmaceuticals, Inc. made up 9.17% of Greylock XI's portfolio in Q3 2015, its #2 holding.
Greylock XI first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and has held it in 10 quarters since.
Greylock XI's AVEO Pharmaceuticals, Inc. position peaked at $1.46M in Q2 2013.
48 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2015.

Based on Greylock XI's 13F filing for Q3 2015, filed 4 Nov 2015.